Vera <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Unveils New Employee Compensation Plan with Inducement Stock Options and RSUs
BRISBANE, Calif., Aug. 08, 2025 - Vera Therapeutics, Inc. (Nasdaq: VERA) has disclosed the granting of inducement awards to eight new employees under its 2024 Inducement Plan, as approved by the company's Compensation Committee. On August 4, 2025, the awarded inducements included non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) for 48,200 shares. The stock options carry an exercise price of $20.45 per share, matching the closing trading price on the grant date, and will vest over four years. RSUs are set to vest annually over the same period, beginning on August 20, 2025. These awards are in accordance with Nasdaq Listing Rule 5635(c)(4), contingent on continued employment with Vera.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9508297-en) on August 08, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。